Reduction and persistence of co-circulating respiratory viruses during the SARS-CoV-2 pandemic

To evaluate the co-circulation of respiratory viruses during the SARS-CoV-2 Alpha surge, we performed a molecular respiratory panel on 1,783 nasopharyngeal swabs collected between January 15 and April 15, 2021, from symptomatic outpatients that tested negative for SARS-CoV-2 in North Carolina. Of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Smedberg, Jason R., DiBiase, Lauren M., Hawken, Shawn E., Allen, Anika, Mohan, Suniti, Santos, Courtney, Smedberg, Tandy, Barzin, Amir H., Wohl, David A., Miller, Melissa B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188982/
https://www.ncbi.nlm.nih.gov/pubmed/35709970
http://dx.doi.org/10.1016/j.ajic.2022.06.008
Descripción
Sumario:To evaluate the co-circulation of respiratory viruses during the SARS-CoV-2 Alpha surge, we performed a molecular respiratory panel on 1,783 nasopharyngeal swabs collected between January 15 and April 15, 2021, from symptomatic outpatients that tested negative for SARS-CoV-2 in North Carolina. Of these, 373 (20.9%) were positive for at least 1 virus tested on the panel. Among positive tests, over 90% were positive for rhinovirus and/or enterovirus, either as a single infection or coinfection, illustrating persistent co-circulation of some respiratory viruses despite active infection control measures.

Ejemplares similares